Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ChemoCentryx
Pharma
EU regulators offer post-mortem of Tavneos withdrawal decision
EU regulators have outlined concerns that led to last week's formal revocation of the marketing authorization for the rare-disease med Tavneos.
Fraiser Kansteiner
Aug 14, 2026 11:04am
Amgen submits analyses to FDA in bid for Tavneos hearing
Jul 24, 2026 10:50am
Amgen to file 3rd-party review of Tavneos data for FDA hearing
Jun 12, 2026 11:12am
Tavneos patient starts resume in Japan amid safety scrutiny
May 21, 2026 11:38am
FDA takes first steps in withdrawing approval of Amgen's Tavneos
Apr 28, 2026 11:37am
With trial data in question, FDA asks Amgen to ground Tavneos
Feb 4, 2026 7:55am
